Yıl: 2018 Cilt: 2 Sayı: 3 Sayfa Aralığı: 224 - 230 Metin Dili: Türkçe İndeks Tarihi: 23-05-2019

Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi

Öz:
Anormal posterior vitreus dekolmanı, vitreoretinal arayüzey hastalıklarının patogenezinde önemli bir basamaktır.Vitreoretinal arayüzey hastalıklarının patofizyolojisini anlayabilmek için; vitreusun yapısı, biyokimyası ve onun retina ileolan ilişkisi incelenmelidir. Bu hastalıkların patofizyolojisinin net bir şekilde anlaşılması, yeni farmakolojik veya cerrahitedavilerin geliştirilmesine yardımcı olabilir.
Anahtar Kelime:

Konular: Cerrahi

The Pathophysiology of Vitreomacular Interface Disease

Öz:
Anomalous posterior vitreous detachment is an important step in the pathogenesis of vitreoretinal interface diseases. In order to understand the pathophysiology of vitreoretinal interface diseases, the structure and biochemistry of the vitreous body, and its relation with the retina should be investigated. Having a clear understanding of the pathophysiology of these diseases may help to develop new pharmacologic or surgical treatment modalities..
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik
  • de Smet MD, Gad Elkareem AM, Zwinderman AH. The vitreous, the retinal interface in ocular health and disease. Ophthalmologica. 2013; 230(4):165- 178.
  • Snowden JM. The stabilization of in vivo assembled collagen fibrils by proteoglycans/glycosaminoglycans. Biochim Biophys Acta. 1982;703(1):21-25.
  • Schmut O, Mallinger R, Paschke E. Studies on a distinct fraction of bovine vitreous body collagen. Graefes Arch Clin Exp Ophthalmol 1984;221(6):286- 289.
  • Maumenee IH. Vitreoretinal degeneration as a sign of generalized connective tissue diseases. Am J Ophthalmol. 1979;88(3 Pt 1):432-449.
  • Bishop PN, Crossman MV, McLeod D, Ayad S. Extraction and characterization of the tissue forms of collagen types II and IX from bovine vitreous. Biochem J. 1994;299 ( Pt 2):497-505.
  • Bishop PN, Reardon AJ, McLeod D, Ayad S. Identification of alternatively spliced variants of type II procollagen in vitreous. Biochem Biophys Res Commun. 1994;203(1):289-295.
  • Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res. 2000;19(3):323-344.
  • Reardon AJ, Le Goff M, Briggs MD, McLeod D, Sheehan JK, Thornton DJ, et al. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem. 2000;275(3):2123-2129.
  • Sanders EJ, Walter MA, Parker E, Aramburo C, Harvey S. Opticin binds retinal growth hormone in the embryonic vitreous. Invest Ophthalmol Vis Sci. 2003;44(12):5404-5409.
  • Hindson VJ, Gallagher JT, Halfter W, Bishop PN. Opticin binds to heparan and chondroitin sulfate proteoglycans. Invest Ophthalmol Vis Sci. 2005;46(12):4417-4423.
  • Monfort J, Tardif G, Roughley P, Reboul P, Boileau C, Bishop PN, et al. Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis. Osteoarthritis Cartilage. 2008;16(7):749-755.
  • Cain SA, Morgan A, Sherratt MJ, Ball SG, Shuttleworth CA, Kielty CM. Proteomic analysis of fibrillin-rich microfibrils. Proteomics. 2006;6(1):111- 122.
  • Osterlin SE, Jacobson B. The synthesis of hyaluronic acid in vitreous. I. Soluble and particulate transferases in hyalocytes. Exp Eye Res. 1968;7(4):497- 510.
  • Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev. 1978;58(1):255-315.
  • Sebag J. Diabetic vitreopathy. Ophthalmology. 1996;103(2):205-206.
  • Cohen AI. Electron microscopic observations of the internal limiting membrane and optic fiber layer of the retina of the Rhesus monkey (M. mulatta). Am J Anat. 1961;108:179-197.
  • Los LI, van Luyn MJ, Nieuwenhuis P. Organization of the rabbit vitreous body: lamellae, Cloquet’s channel and a novel structure, the ‘alae canalis Cloqueti’. Exp Eye Res. 1999;69(3):343-350.
  • Bu SC, Kuijer R, van der Worp RJ, Li XR, Hooymans JM, Los LI. The Ultrastructural Localization of Type II, IV, and VI Collagens at the Vitreoretinal Interface. PLoS One. 2015;10(7):323-325.
  • Halfter W, Dong S, Dong A, Eller AW, Nischt R. Origin and turnover of ECM proteins from the inner limiting membrane and vitreous body. Eye (Lond). 2008;22(10):1207-1213.
  • Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28(3):506-514.
  • Sasaki T, Forsberg E, Bloch W, Addicks K, Fassler R, Timpl R. Deficiency of beta 1 integrins in teratoma interferes with basement membrane assembly and laminin-1 expression. Exp Cell Res. 1998;238(1):70-81.
  • Aumailley M, Pesch M, Tunggal L, Gaill F, Fassler R. Altered synthesis of laminin 1 and absence of basement membrane component deposition in (beta)1 integrin-deficient embryoid bodies. J Cell Sci. 2000;113 (Pt 2):259-268.
  • Timpl R, Brown JC. Supramolecular assembly of basement membranes. Bioessays. 1996;18(2):123-132.
  • Aumailley M, Wiedemann H, Mann K, Timpl R. Binding of nidogen and the laminin-nidogen complex to basement membrane collagen type IV. Eur J Biochem. 1989;184(1):241-248.
  • Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem. 1997;272(42):26522-26529.
  • Sebag J. Age-related differences in the human vitreoretinal interface. Arch Ophthalmol. 1991;109(7):966-971.
  • Candiello J, Cole GJ, Halfter W. Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane. Matrix Biol. 2010;29(5):402-410.
  • Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development. 2004;131(7):1619-1628.
  • Halfter W, Willem M, Mayer U. Basement membrane-dependent survival of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2005;46(3):1000-1009.
  • Sebag J, Hageman GS. Interfaces. Eur J Ophthalmol. 2000;10(1):1-3.
  • Teng CC, Chi HH. Vitreous changes and the mechanism of retinal detachment. Am J Ophthalmol. 1957;44(3):335-356.
  • Hogan MJ. The Vitreous, Its Structure, and Relation to the Ciliary Body and Retina. Proctor Award Lecture. Invest Ophthalmol. 1963;2:418-445.
  • Byer NE. Cystic retinal tufts and their relationship to retinal detachment. Arch Ophthalmol. 1981;99(10):1788-1790.
  • Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol. 1987;225(2):89-93.
  • Sebag J. Ageing of the vitreous. Eye (Lond). 1987;1 ( Pt 2):254-262.
  • Sebag J, Balazs EA. Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci. 1989;30(8):1867-1871.
  • Kamei A, Totani A. Isolation and characterization of minor glycosaminoglycans in the rabbit vitreous body. Biochem Biophys Res Commun. 1982;109(3):881-887.
  • Aguayo J, Glaser B, Mildvan A, Cheng HM, Gonzalez RG, Brady T. Study of vitreous liquifaction by NMR spectroscopy and imaging. Invest Ophthalmol. Vis Sci 1985;26(5):692-697.
  • Foos RY. Vitreoretinal juncture; topographical variations. Invest Ophthalmol. 1972;11(10):801-808.
  • Ponsioen TL, Hooymans JM, Los LI. Remodelling of the human vitreous and vitreoretinal interface--a dynamic process. Prog Retin Eye Res. 2010;29(6):580-595.
  • Johnson MW. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc. 2005;103:537-567.
  • Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol. 2010;149(3):371-382.
  • Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol. 2004;242(8):690- 698.
  • Sebag J. Vitreopapillary traction as a cause of elevated optic nerve head. Am J Ophthalmol. 1999;128(2):261-262.
  • Bishop PN, Holmes DF, Kadler KE, McLeod D, Bos KJ. Age-related changes on the surface of vitreous collagen fibrils. Invest Ophthalmol Vis Sci. 2004;45(4):1041-1046.
  • Uchino E, Uemura A, Ohba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol. 2001;119(10):1475-1479.
  • Sebag J, Wang MY, Nguyen D, Sadun AA. Vitreopapillary adhesion in macular diseases. Trans Am Ophthalmol Soc. 2009;107:35-44.
  • Gandorfer A, Rohleder M, Kampik A. Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol. 2002;86(8):902-909.
  • Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol. 2008;246(3):329-332.
  • Krebs I, Glittenberg C, Zeiler F, Binder S. Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration. Br J Ophthalmol. 2011;95(10):1415-1418.
  • Lindqvist N, Liu Q, Zajadacz J, Franze K, Reichenbach A. Retinal glial (Muller) cells: sensing and responding to tissue stretch. Invest Ophthalmol Vis Sci. 2010;51(3):1683-1690.
  • Kodal H, Weick M, Moll V, Biedermann B, Reichenbach A, Bringmann A. Involvement of calcium-activated potassium channels in the regulation of DNA synthesis in cultured Muller glial cells. Invest Ophthalmol Vis Sci. 2000;41(13):4262-4267.
  • Schumann RG, Eibl KH, Zhao F, et al. Immunocytochemical and ultrastructural evidence of glial cells and hyalocytes in internal limiting membrane specimens of idiopathic macular holes. Invest Ophthalmol Vis Sci. 2011;52(11):7822-7834.
  • Ikeda T, Nakamura K, Oku H, et al. The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes. Clin Ophthalmol. 2015;9:1181-1186.
  • Gupta P, Yee KM, Garcia P, Rosen RB, Parikh J, Hageman GS, et al. Vitreoschisis in macular diseases. Br J Ophthalmol. 2011;95(3):376-380.
  • Schwatz SD, Alexander R, Hiscott P, Gregor ZJ. Recognition of vitreoschisis in proliferative diabetic retinopathy: A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology. 1996;103(2):323-328.
  • Parolini B, Schumann RG, Cereda MG, Haritoglou C, Pertile G. Lamellar macular hole: a clinicopathologic correlation of surgically excised epiretinal membranes. Invest Ophthalmol Vis Sci. 2011;52(12):9074-9083.
  • Schumann RG, Rohleder M, Schaumberger MM, Haritoglou C, Kampik A, Gandorfer A. Idiopathic macular holes: ultrastructural aspects of surgical failure. Retina. 2008;28(2):340-349.
  • Gandorfer A, Scheler R, Schumann R, Haritoglou C, Kampik A. Interference microscopy delineates cellular proliferations on flat mounted internal limiting membrane specimens. Br J Ophthalmol. 2009;93(1):120-122.
  • Yoshida M, Kishi S. Pathogenesis of macular hole recurrence and its prevention by internal limiting membrane peeling. Retina. 2007;27(2):169-173.
  • Kampik A, Green WR, Michels RG, Nase PK. Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol. 1980;90(6):797-809.
  • Smiddy WE, Maguire AM, Green WR, Michels RG, de la Cruz Z, Enger C, et al. Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology. 1989;96(6):811-821.
  • Wallow IH, Stevens TS, Greaser ML, Bindley C, Wilson R. Actin filaments in contracting preretinal membranes. Arch Ophthalmol. 1984;102(9):1370- 1375.
  • Bringmann A, Wiedemann P. Involvement of Muller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol. 2009;247(7):865-883.
  • Sakamoto T, Ishibashi T. Hyalocytes: essential cells of the vitreous cavity in vitreoretinal pathophysiology? Retina. 2011;31(2):222-228.
  • Gandorfer A, Haritoglou C, Scheler R, Schumann R, Zhao F, Kampik A. Residual cellular proliferation on the internal limiting membrane in macular pucker surgery. Retina. 2012;32(3):477-485.
APA BİRİNCİ H, YETER V (2018). Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. , 224 - 230.
Chicago BİRİNCİ Hakkı,YETER VOLKAN Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. (2018): 224 - 230.
MLA BİRİNCİ Hakkı,YETER VOLKAN Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. , 2018, ss.224 - 230.
AMA BİRİNCİ H,YETER V Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. . 2018; 224 - 230.
Vancouver BİRİNCİ H,YETER V Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. . 2018; 224 - 230.
IEEE BİRİNCİ H,YETER V "Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi." , ss.224 - 230, 2018.
ISNAD BİRİNCİ, Hakkı - YETER, VOLKAN. "Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi". (2018), 224-230.
APA BİRİNCİ H, YETER V (2018). Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. Güncel Retina Dergisi, 2(3), 224 - 230.
Chicago BİRİNCİ Hakkı,YETER VOLKAN Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. Güncel Retina Dergisi 2, no.3 (2018): 224 - 230.
MLA BİRİNCİ Hakkı,YETER VOLKAN Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. Güncel Retina Dergisi, vol.2, no.3, 2018, ss.224 - 230.
AMA BİRİNCİ H,YETER V Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. Güncel Retina Dergisi. 2018; 2(3): 224 - 230.
Vancouver BİRİNCİ H,YETER V Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi. Güncel Retina Dergisi. 2018; 2(3): 224 - 230.
IEEE BİRİNCİ H,YETER V "Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi." Güncel Retina Dergisi, 2, ss.224 - 230, 2018.
ISNAD BİRİNCİ, Hakkı - YETER, VOLKAN. "Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi". Güncel Retina Dergisi 2/3 (2018), 224-230.